Target intelligence / Profile preview

Multiple myeloma idiotypic immunoglobulin (M-protein idiotype) (M-protein idiotype)

Target
M-protein idiotype
Molecular classification
Immunoglobulin, Glycoprotein, Tumor-associated antigen
01

Overview

The multiple myeloma idiotypic immunoglobulin, commonly known as the M-protein idiotype, represents the unique set of antigenic determinants located within the variable regions of the monoclonal antibody produced by a malignant plasma cell clone (Radl J., 1988). In the 5T2MM murine model, which serves as a highly relevant system for studying human multiple myeloma, this protein is expressed on the surface of tumor cells and secreted into the circulation, acting as a definitive tumor-specific antigen (Asosingh K., et al., 2000). Because the idiotype is unique to the malignant clone and absent from normal B cells, it is an ideal target for personalized immunotherapies, such as idiotype-pulsed dendritic cell vaccines or anti-idiotype antibodies, designed to elicit a specific cytotoxic T-lymphocyte response (Yi Q., et al., 2002). While the secreted M-protein contributes to disease pathology, including renal impairment, its role as a target focuses on the immune-mediated destruction of the underlying plasma cell malignancy (Bakkus MH., et al., 2003). Despite the high specificity of this approach, challenges remain regarding the logistical complexity of patient-specific vaccine production and the potential for tumor escape through the selection of idiotype-negative variants.

Other names
5T2MM idiotypic M-proteinMyeloma idiotypeTumor-specific idiotypeMonoclonal protein idiotypeParaprotein idiotype
02

Mechanism of action

Induction of a specific immune response (cellular and humoral) against the unique variable regions (idiotypes) of the monoclonal immunoglobulin expressed by malignant plasma cells.

03

Biological functions

Immune responseAntigen binding
04

Disease associations

Multiple myelomaPlasma cell dyscrasia
05

Safety considerations

Antigenic escape (loss of idiotype expression)Low immunogenicity of self-derived proteinsLogistical complexity of personalized therapy manufacturing
06

Interacting drugs

Idiotype-pulsed dendritic cell vaccine

2 more in the full profile.

07

Biomarkers

Serum M-protein levelIdiotype-specific T-cell responseClonal immunoglobulin gene rearrangement

Beyond the preview

Go deeper on Multiple myeloma idiotypic immunoglobulin (M-protein idiotype) (M-protein idiotype).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple myeloma idiotypic immunoglobulin (M-protein idiotype) (M-protein idiotype).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call